Enhanced FDA Oversight Added To GAO’s “High Risk” List
This article was originally published in The Tan Sheet
Executive Summary
The Government Accountability Office has added enhanced oversight of devices, drugs and other medical products to its list of "high risk" priorities
You may also be interested in...
Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA
FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say
Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA
FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say
FDA Commissioner Announcement Complicated By Daschle, Peanut Butter
The withdrawal of Tom Daschle's nomination as Health and Human Services secretary may pose a hurdle to the Obama administration's impetus to name an FDA commissioner, but does not change the two names on the shortlist